1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS AND EXCLUSIONS 41
1.3 MARKET SCOPE 41
1.3.1 MARKET COVERED 41
1.3.2 YEARS CONSIDERED FOR THE STUDY 43
1.4 CURRENCY 43
1.5 LIMITATIONS 43
1.6 STAKEHOLDERS 43
1.7 SUMMARY OF CHANGES 44
1.8 LIMITATIONS OF THE CURRENT EDITION 44

2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
FIGURE 1 RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 Key data from secondary sources 47
2.2 PRIMARY DATA 47
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS 48
2.3 MARKET SIZE ESTIMATION 48
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 49
2.3.1 BOTTOM-UP APPROACH 49
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH CRM DEVICES MARKET 50
2.3.2 GROWTH FORECAST 50
2.3.3 TOP-DOWN APPROACH 50
FIGURE 5 TOP-DOWN APPROACH 51
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 6 MARKET DATA TRIANGULATION METHODOLOGY 52
2.5 ASSUMPTIONS FOR THE STUDY 53

3 EXECUTIVE SUMMARY 54
FIGURE 7 CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 54
FIGURE 8 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 55
FIGURE 9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 55
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET 56

4 PREMIUM INSIGHTS 57
4.1 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW 57
FIGURE 11 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH 57
4.2 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE AND COUNTRY (2019) 58
FIGURE 12 DEFIBRILLATORS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019 58
4.3 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
FIGURE 13 CHINA TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 59

5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
FIGURE 14 CM & CRM DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 60
5.2.1 DRIVERS 61
5.2.1.1 Rising prevalence of cardiovascular disease 61
FIGURE 15 INCIDENCE OF CVD, BY REGION, 2017 61
5.2.1.2 Availability of reimbursement for CM & CRM devices 62
TABLE 1 CPT CODES FOR CM & CRM DEVICES, 2020 62
5.2.1.3 Launch of innovative products by market players 62
TABLE 2 RECENT PRODUCT LAUNCHES IN THE CM & CRM DEVICES MARKET 62
5.2.1.4 Increasing investments, funds, and grants for research on CM & CRM devices 63
5.2.1.5 Growing preference for wearable cardiac devices 64
5.2.2 RESTRAINTS 64
5.2.2.1 Frequent product recalls 64
TABLE 3 KEY PRODUCT RECALLS 65
5.2.3 CHALLENGES 65
5.2.3.1 Risk of associated cybersecurity vulnerabilities 65
5.2.3.2 Stringent regulatory requirements delaying the approval of cardiac devices 66
5.2.3.3 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices 66
5.2.4 OPPORTUNITIES 66
5.2.4.1 Measures to reduce infections caused due to CIEDs 66
5.3 VALUE CHAIN ANALYSIS 67
FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 67
FIGURE 17 DIRECT DISTRIBUTION?THE PREFERRED STRATEGY FOR PROMINENT COMPANIES 69
5.4 ECOSYSTEM ANALYSIS 69
FIGURE 18 ECOSYSTEM ANALYSIS OF THE CARDIOVASCULAR DEVICES MARKET 69
5.5 AVERAGE SELLING PRICE TREND 70
FIGURE 19 AVERAGE PRICE FOR ECG DEVICES, 2019 VS. 2022 VS. 2025 (USD/UNIT) 70
5.5.1 COVID-19 IMPACT ON THE CM & CRM DEVICES MARKET 71

6 CARDIAC MONITORING DEVICES MARKET, BY TYPE 72
6.1 INTRODUCTION 73
TABLE 4 CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 73
TABLE 5 CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 73
TABLE 6 ECG DEVICES & EVENT MONITORS MARKET, BY TYPE, 2018–2025 (UNITS) 74
6.2 ECG DEVICES 74
TABLE 7 ECG DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 74
TABLE 8 ECG DEVICES MARKET, BY TYPE, 2020–2025 (USD MILLION) 74
TABLE 9 ECG DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION) 75
TABLE 10 ECG DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION) 75
6.2.1 RESTING ECG DEVICES 75
6.2.1.1 Low cost, ease of use, and simplicity have driven the adoption of resting ECG devices 75
TABLE 11 RESTING ECG DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION) 76
TABLE 12 RESTING ECG DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION) 76
6.2.2 STRESS ECG DEVICES 76
6.2.2.1 Their flexibility of use has driven the demand for stress ECG devices, but high cost has negatively affected the market 76
TABLE 13 STRESS ECG DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION) 77
TABLE 14 STRESS ECG DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION) 77
6.2.3 HOLTER MONITORS 77
6.2.3.1 Short duration of monitoring is a key restraint to market growth 77
TABLE 15 HOLTER MONITORS MARKET, BY REGION, 2016–2019 (USD MILLION) 78
TABLE 16 HOLTER MONITORS MARKET, BY REGION, 2020–2025 (USD MILLION) 78
6.3 IMPLANTABLE LOOP RECORDERS 78
6.3.1 HIGH COST AND LIMITED APPLICATIONS HAVE HINDERED DEMAND GROWTH 78
TABLE 17 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION,
2016–2019 (USD MILLION) 79
TABLE 18 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION,
2020–2025 (USD MILLION) 79
6.4 MOBILE CARDIAC TELEMETRY DEVICES 79
6.4.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS IS PROPELLING MARKET GROWTH 79
TABLE 19 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 80
TABLE 20 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 80
6.5 CARDIAC OUTPUT MONITORING DEVICES 80
6.5.1 INCREASING NUMBER OF CARDIAC SURGERIES WILL DRIVE THE DEMAND FOR COM DEVICES 80
TABLE 21 TYPES OF COM DEVICES 80
TABLE 22 CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 81
TABLE 23 CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 81
6.6 EVENT MONITORS 82
TABLE 24 EVENT MONITORS MARKET, BY REGION, 2016–2019 (USD MILLION) 82
TABLE 25 EVENT MONITORS MARKET, BY REGION, 2020–2025 (USD MILLION) 82
6.6.1 EVENT MONITORS MARKET, BY TYPE 83
TABLE 26 EVENT MONITORS MARKET, BY TYPE, 2016–2019 (USD MILLION) 83
TABLE 27 EVENT MONITORS MARKET, BY TYPE, 2020–2025 (USD MILLION) 83
6.6.1.1 Pre-symptom event monitors 83
6.6.1.1.1 Large storage capacity of pre-symptom event monitors makes them ideal for long-term monitoring 83
TABLE 28 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION,
2016–2019 (USD MILLION) 84
TABLE 29 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION,
2020–2025 (USD MILLION) 84
6.6.1.2 Post-symptom event monitors 84
6.6.1.2.1 The emergence of handheld, wireless, and remote monitors will drive market growth 84
TABLE 30 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION,
2016–2019 (USD MILLION) 85
TABLE 31 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION,
2020–2025 (USD MILLION) 85
6.6.2 EVENT MONITORS MARKET, BY TECHNOLOGY 85
6.6.2.1 Autodetect monitors 85
6.6.2.1.1 Autodetect monitors are ideal for patients who are unable to trigger monitors reliably 85
6.6.2.2 Manual event monitors 85
6.6.2.2.1 Manual monitors can be pre-symptom or post-symptom, but rely on the patient to be triggered 85
6.7 SMART ECG MONITORS 86
6.7.1 LACK OF DATA SECURITY HINDERS THE GROWTH OF THE SMART MONITORS MARKET TO SOME EXTENT 86
TABLE 32 INDICATIVE LIST OF SMART ECG MONITORS 86
TABLE 33 SMART ECG MONITORS MARKET, BY REGION, 2016–2019 (USD MILLION) 87
TABLE 34 SMART ECG MONITORS MARKET, BY REGION, 2020–2025 (USD MILLION) 87
6.8 COVID-19 IMPACT ANALYSIS 87
_
7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE 89
7.1 INTRODUCTION 90
TABLE 35 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 90
TABLE 36 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 90
TABLE 37 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2018–2025 (UNITS) 90
7.2 DEFIBRILLATORS 91
TABLE 38 DEFIBRILLATORS MARKET, BY TYPE, 2016–2019 (USD MILLION) 91
TABLE 39 DEFIBRILLATORS MARKET, BY TYPE, 2020–2025 (USD MILLION) 91
TABLE 40 DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION) 91
TABLE 41 DEFIBRILLATORS MARKET, BY REGION, 2020–2025 (USD MILLION) 92
7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 92
TABLE 42 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2016–2019 (USD MILLION) 92
TABLE 43 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2020–2025 (USD MILLION) 93
TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION) 93
TABLE 45 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020–2025 (USD MILLION) 93
7.2.1.1 Transvenous implantable cardioverter defibrillators (T-ICDs) 94
TABLE 46 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2016–2019 (USD MILLION) 94
TABLE 47 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2020–2025 (USD MILLION) 94
TABLE 48 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2016–2019 (USD MILLION) 95
TABLE 49 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2020–2025 (USD MILLION) 95
7.2.1.1.1 Biventricular ICDS/CRT-Ds 95
7.2.1.1.1.1 Biventricular ICDs/CRT-Ds are preferred for heart failure patients 95
TABLE 50 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION) 96
TABLE 51 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2020–2025 (USD MILLION) 96
7.2.1.1.2 Dual-chamber ICDs 96
7.2.1.1.2.1 The benefits of dual-chamber ICDs, such as higher diagnostic accuracy, make them ideal for patients with tachycardia episodes 96
TABLE 52 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION) 97
TABLE 53 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020–2025 (USD MILLION) 97
7.2.1.1.3 Single-chamber ICDs 97
7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs will drive market growth 97
TABLE 54 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION) 98
TABLE 55 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020–2025 (USD MILLION) 98
7.2.1.2 Subcutaneous implantable cardioverter defibrillators 98
7.2.1.2.1 Safety and efficacy of S-ICDs in the prevention of sudden cardiac arrest will boost their adoption 98
TABLE 56 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION) 99
TABLE 57 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020–2025 (USD MILLION) 99
7.2.2 EXTERNAL DEFIBRILLATORS 99
TABLE 58 EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2016–2019 (USD MILLION) 100
TABLE 59 EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2020–2025 (USD MILLION) 100
TABLE 60 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016–2019 (USD MILLION) 100
TABLE 61 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020–2025 (USD MILLION) 101
7.2.2.1 Automated external defibrillators 101
TABLE 62 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED PREMARKET APPROVAL FROM THE FDA (2018–2019) 101
TABLE 63 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2016–2019 (USD MILLION) 102
TABLE 64 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2020–2025 (USD MILLION) 102
TABLE 65 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2016–2019 (USD MILLION) 102
TABLE 66 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2020–2025 (USD MILLION) 103
7.2.2.1.1 Semi-automated external defibrillators 103
7.2.2.1.1.1 Semi-automated external defibrillators accounted for the largest share of the AEDs market in 2018 103
7.2.2.1.2 Fully automated external defibrillators 103
7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy will drive market growth 103
7.2.2.2 Manual external defibrillators 104
7.2.2.2.1 North America dominates the manual defibrillators market 104
TABLE 67 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2016–2019 (USD MILLION) 104
TABLE 68 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2020–2025 (USD MILLION) 104
7.2.2.3 Wearable cardioverter defibrillators 105
7.2.2.3.1 Ease of use and the noninvasive nature of wearable cardioverter defibrillators will support market growth 105
TABLE 69 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION,
2016–2019 (USD MILLION) 105
TABLE 70 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION,
2020–2025 (USD MILLION) 105
7.3 PACEMAKERS 106
TABLE 71 PACEMAKERS MARKET, BY REGION, 2016–2019 (USD MILLION) 106
TABLE 72 PACEMAKERS MARKET, BY REGION, 2020–2025 (USD MILLION) 106
7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY 106
TABLE 73 PACEMAKERS MARKET, BY IMPLANTABILITY, 2016–2019 (USD MILLION) 106
TABLE 74 PACEMAKERS MARKET, BY IMPLANTABILITY, 2020–2025 (USD MILLION) 107
7.3.1.1 Implantable pacemakers 107
7.3.1.1.1 Introduction of leadless and MRI-safe devices has boosted device popularity 107
TABLE 75 IMPLANTABLE PACEMAKERS MARKET, BY REGION,
2016–2019 (USD MILLION) 107
TABLE 76 IMPLANTABLE PACEMAKERS MARKET, BY REGION,
2020–2025 (USD MILLION) 108
7.3.1.2 External pacemakers 108
7.3.1.2.1 Increasing number of open-heart surgeries will drive the demand for external pacemakers 108
TABLE 77 EXTERNAL PACEMAKERS MARKET, BY REGION, 2016–2019 (USD MILLION) 108
TABLE 78 EXTERNAL PACEMAKERS MARKET, BY REGION, 2020–2025 (USD MILLION) 109
7.3.2 PACEMAKERS MARKET, BY TYPE 109
TABLE 79 PACEMAKERS MARKET, BY TYPE, 2016–2019 (USD MILLION) 109
TABLE 80 PACEMAKERS MARKET, BY TYPE, 2020–2025 (USD MILLION) 109
7.3.2.1 Dual-chamber pacemakers 110
7.3.2.1.1 Dual-chamber pacemakers are the most commonly implanted pacemakers for bradycardia 110
TABLE 81 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION,
2016–2019 (USD MILLION) 110
TABLE 82 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION,
2020–2025 (USD MILLION) 110
7.3.2.2 Single-chamber pacemakers 110
7.3.2.2.1 Introduction of leadless pacemakers will stimulate demand in this product segment 110
TABLE 83 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 84 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION,
2020–2025 (USD MILLION) 111
7.3.2.3 Biventricular/CRT pacemakers 111
7.3.2.3.1 High cost and unfavorable reimbursement scenario have hindered market growth 111
TABLE 85 BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION,
2016–2019 (USD MILLION) 112
TABLE 86 BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION,
2020–2025 (USD MILLION) 112
7.4 COVID-19 IMPACT ANALYSIS 112

8 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER 113
8.1 INTRODUCTION 114
TABLE 87 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016–2019 (USD MILLION) 114
TABLE 88 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION) 114
8.2 HOSPITALS 114
8.2.1 GROWING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET GROWTH 114
TABLE 89 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2016–2019 (USD MILLION) 115
TABLE 90 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2020–2025 (USD MILLION) 115
8.3 CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS 116
8.3.1 GROWING FOCUS ON AMBULATORY CARE IN THE US TO DRIVE THE ADOPTION OF CM & CRM DEVICES 116
TABLE 91 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2016–2019 (USD MILLION) 116
TABLE 92 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2020–2025 (USD MILLION) 117
8.4 OTHER END USERS 117
TABLE 93 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2016–2019 (USD MILLION) 117
TABLE 94 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020–2025 (USD MILLION) 118
8.5 COVID-19 IMPACT ANALYSIS 118
9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION 119
9.1 INTRODUCTION 120
TABLE 95 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION) 120
TABLE 96 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2020–2025 (USD MILLION) 120
TABLE 97 CARDIAC MONITORING DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 121
TABLE 98 CARDIAC MONITORING DEVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 121
TABLE 99 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 121
TABLE 100 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION,
2020–2025 (USD MILLION) 122
_
9.2 NORTH AMERICA 122
FIGURE 20 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT 123
TABLE 101 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 124
TABLE 102 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 124
TABLE 103 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 124
TABLE 104 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 124
TABLE 105 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET,
BY COUNTRY, 2016–2019 (USD MILLION) 125
TABLE 106 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET,
BY COUNTRY, 2020–2025 (USD MILLION) 125
TABLE 107 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 125
TABLE 108 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 126
TABLE 109 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 126
TABLE 110 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 126
TABLE 111 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE,
2016–2019 (USD MILLION) 127
TABLE 112 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE,
2020–2025 (USD MILLION) 127
TABLE 113 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET,
BY TYPE, 2016–2019 (USD MILLION) 127
TABLE 114 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET,
BY TYPE, 2020–2025 (USD MILLION) 127
TABLE 115 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE,
2016–2019 (USD MILLION) 128
TABLE 116 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE,
2020–2025 (USD MILLION) 128
TABLE 117 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016–2019 (USD MILLION) 128
TABLE 118 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020–2025 (USD MILLION) 128
TABLE 119 NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2016–2019 (USD MILLION) 129
TABLE 120 NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2020–2025 (USD MILLION) 129
TABLE 121 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2016–2019 (USD MILLION) 129
TABLE 122 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2020–2025 (USD MILLION) 130
TABLE 123 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY,
2016–2019 (USD MILLION) 130
TABLE 124 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY,
2020–2025 (USD MILLION) 130
TABLE 125 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE,
2016–2019 (USD MILLION) 130
TABLE 126 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE,
2020–2025 (USD MILLION) 131
TABLE 127 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016–2019 (USD MILLION) 131
TABLE 128 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION) 131
9.2.1 US 132
9.2.1.1 Growing number of FDA approvals for CM & CRM devices to support market growth in the US 132
TABLE 129 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 132
TABLE 130 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 133
TABLE 131 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 133
TABLE 132 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 133
TABLE 133 US: DEFIBRILLATORS MARKET, BY TYPE, 2016–2019 (USD MILLION) 134
TABLE 134 US: DEFIBRILLATORS MARKET, BY TYPE, 2020–2025 (USD MILLION) 134
TABLE 135 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016–2019 (USD MILLION) 134
TABLE 136 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020–2025 (USD MILLION) 134
TABLE 137 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016–2019 (USD MILLION) 135
TABLE 138 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION) 135
9.2.2 CANADA 135
9.2.2.1 Growing focus of government and private organizations on providing funding for research to drive market growth 135
TABLE 139 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 136
TABLE 140 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2020–2025 (USD MILLION) 136
TABLE 141 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 137
TABLE 142 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2025 (USD MILLION) 137
TABLE 143 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2016–2019 (USD MILLION) 137
TABLE 144 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2020–2025 (USD MILLION) 137
TABLE 145 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY,
2016–2019 (USD MILLION) 138
TABLE 146 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY,
2020–2025 (USD MILLION) 138
TABLE 147 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016–2019 (USD MILLION) 138
TABLE 148 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020–2025 (USD MILLION) 138